These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2045201

  • 21. The specificity of lymphokine-activated killer (LAK) cells in vitro: fresh normal murine tissues are resistant to LAK-mediated lysis.
    Lefor AT, Rosenberg SA.
    J Surg Res; 1991 Jan; 50(1):15-23. PubMed ID: 1987427
    [Abstract] [Full Text] [Related]

  • 22. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR, Sassenfeld HM, Widmer MB.
    J Exp Med; 1990 Aug 01; 172(2):577-87. PubMed ID: 2142722
    [Abstract] [Full Text] [Related]

  • 23. Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro.
    Helfand SC, Soergel SA, Modiano JF, Hank JA, Sondel PM.
    Cancer Biother; 1994 Aug 01; 9(3):237-44. PubMed ID: 7820185
    [Abstract] [Full Text] [Related]

  • 24. Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function.
    Iho S, Shau HY, Golub SH.
    Cell Immunol; 1991 Jun 01; 135(1):66-77. PubMed ID: 2018984
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.
    Leung KH.
    Cell Immunol; 1989 Oct 15; 123(2):384-95. PubMed ID: 2507171
    [Abstract] [Full Text] [Related]

  • 26. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C, García-Pérez MJ, Ramirez R, Martín C, Alvarez MA, Martinez F, Gómez P, García-Castellano JM, Torres A.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):545-51. PubMed ID: 9085733
    [Abstract] [Full Text] [Related]

  • 27. Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity.
    Kawase I, Komuta K, Shirasaka T, Hara H, Tanio Y, Watanabe M, Saito S, Ikeda T, Masuno T, Kishimoto S.
    Jpn J Cancer Res; 1989 Nov 15; 80(11):1089-97. PubMed ID: 2514171
    [Abstract] [Full Text] [Related]

  • 28. Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithine.
    Susskind BM, Sekar J, Tandon PM, Lind DS, Bear HD.
    Cell Immunol; 1991 Mar 15; 133(1):41-54. PubMed ID: 1899361
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y, Van Eden M, Gatanaga M, Wang FI, Brightbill HD, Granger GA, Gatanaga T.
    Lymphokine Cytokine Res; 1993 Oct 15; 12(5):279-83. PubMed ID: 8260536
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS, Lala PK.
    J Leukoc Biol; 1988 Dec 15; 44(6):474-84. PubMed ID: 2973508
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.